Characterization of the immune landscape in healthy mouse prostate and during prostate cancer progression
Authors:
- Despoina PervizouDPDespoina Pervizou
- Joanna De ChiaraJCJoanna De Chiara
- Lionel SpinelliLionel Spinelli
- Maïa Nestor-MartinMNMaïa Nestor-Martin
- Kateryna Len-TayonKLKateryna Len-Tayon
- Darya YanushkoDYDarya Yanushko
- Frédéric FioreFFFrédéric Fiore
- Marc BajénoffMarc Bajénoff
- Bernard MalissenBernard Malissen
- Daniel MetzgerDaniel Metzger
- Gilles LavernyGilles Laverny
Open Access
- 26 September 2025
- journal article
- Published by Taylor & Francis in OncoImmunology
- Vol. 14 (1) , 2562220
Abstract
The immune landscape of healthy prostate and its alterations during prostate cancer (PCa) progression remain poorly characterized. Using scRNA-sequencing and multiparametric flow-cytometry analysis, we comprehensively characterized immune cells in wild-type and PTEN(i)pe-/- mouse prostates, a model that closely recapitulates human PCa. PCa in PTEN(i)pe-/- is marked by the recruitment of tumor-associated neutrophils (TANs), which represent the dominant immune cell population and resolved into eight distinct states, Trem2+ tumor-associated-macrophages (TAMs), and exhausted CD8+ T cells. Trem2+ TAMs differ from the three main resident macrophage populations in the healthy prostate, exhibiting a strong metabolic and immunosuppressive signature, likely driven by the MIF/HIF1A-signaling axis. This study provides the first detailed characterization of immune cells in the healthy mouse prostate and reveals changes in the immune landscape associated with prostate cancer progression.Keywords
Funding Information
- Fondation ARC pour la Recherche sur le Cancer
- INCA Région Sud, the Institute for Cancer Immunology (ICI) and Canceropôle
- PHENOMIN (ANR-10-INBS-07)
- European Research Council (787300)
- Ministère de l’Enseignement Supérieur et de la Recherche
- Fondation pour la Recherche Médicale
- Fondation ARC pour la Recherche sur le Cancer
- Institut National Du Cancer (INCA2019-191)
- Institut for Cancer Immunology
This publication has 98 references indexed in Scilit:
- An antibody against the colony-stimulating factor 1 receptor depletes the resident subset of monocytes and tissue- and tumor-associated macrophages but does not inhibit inflammationBlood, 2010
- Agouti C57BL/6N embryonic stem cells for mouse genetic resourcesNature Methods, 2009
- Prostate development: a historical perspectiveDifferentiation, 2008
- Temporally controlled ablation of PTEN in adult mouse prostate epithelium generates a model of invasive prostatic adenocarcinomaProceedings of the National Academy of Sciences, 2008
- Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2Nature Immunology, 2006
- Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defectsBlood, 2002
- Insertion of enhanced green fluorescent protein into the lysozyme gene creates mice with green fluorescent granulocytes and macrophages.2000
- Analysis of Fractalkine Receptor CX3CR1 Function by Targeted Deletion and Green Fluorescent Protein Reporter Gene InsertionMolecular and Cellular Biology, 2000
- Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice.Journal of Clinical Investigation, 1997
- The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF 1Cell, 1985